Sign up for Table of Contents Alerts.
Email this page
Print this page
Report
Autophosphorylation Properties of Inactive and Active JNK2
Genaro Pimienta, Scott B. Ficarro, Gustavo J. Gutierrez, Anindita Bhoumik, Eric C. Peters, Zeíev Ronai and Jaime Pascual
volume 6 | issue 14
15 July 2007Pages: 1762 - 1771
Subscribe to this journal for $129/year
The c-Jun N-terminal kinases (JNKs) are ubiquitous proteins that phosphorylate their substrates, such as transcription factors, in response to physical stress, cytokines or UV radiation. This leads to changes in gene expression, ensuing either cell cycle progression or apoptosis. Active phospho JNK1 is the main in vivo kinase component of the JNK cascade, whereas JNK2 is presumed not to participate as a kinase during JNK signalling. However, there is evidence that JNK isoforms interact functionally in vivo. Also, a recent chemical genetics investigation has confirmed that JNK transient activation leads to cellular proliferation, whereas a sustained one is pro-apoptotic. Here we investigate the phosphorylation pattern of JNK2, with protein biochemistry tools and tandem mass spectrometry. We choose to focus on JNK2 because of its reported constitutive activity in glioma cells. Our results indicate that purified JNK2 from transfected non-stressed 293T cells is a mixture of the mono-sites pThr183 and pTyr185 of its activation loop and of pThr386 along its unique C-terminal region. Upon UV stimulation, its phosphorylation stoichiometry is upregulated on the activation loop, generating a mixture of mono-pTyr185 and the expected dual-pThr183/pTyr185 species, with the pThr386 specie present but unaltered respect to the basal conditions.
Authors
Genaro Pimienta
Burnham Institute for Medical Research; La Jolla, California
Scott B. Ficarro
Genomics Institute of the Novartis Research Foundation; La Jolla, California
Gustavo J. Gutierrez
Burnham Institute for Medical Research; La Jolla, California
Anindita Bhoumik
Burnham Institute for Medical Research; La Jolla, California
Eric C. Peters
Genomics Institute of the Novartis Research Foundation ; La Jolla, California
Zeíev Ronai
Burnham Institute for Medical Research; La Jolla, California
Jaime Pascual
Burnham Institute for Medical Research; La Jolla, California




